Benralizumab Biosimilar (IL-5Ra/ CD125 Reference Antibody)
Benralizumab (MEDI-563) is an interleukin-5 receptor α (IL-5Rα) -directed cytolytic monoclonal antibody that induces direct, rapid and nearly complete depletion of eosinophils via enhanced antibody-dependent cell-mediated cytotoxicity. Benralizumab can be used for severe eosinophilic asthma.
Product Specifications
Target
Benralizumab Biosimilar (Anti-IL-5Ra/ CD125 Reference Antibody)
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation
Purity
>98%
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS7041705-01 1 Pair (Sufficient for 5x 96 Well Plates)
UBE2I Antibody Pair
Sign In for Pricing
View Details MBS7041705-02 5x 1 Pair (Sufficient for 25x 96 Well Plates)
UBE2I Antibody Pair
Sign In for Pricing
View Details 
DLR-SYK-Hu-48T 48 Tests
Human Spleen Tyrosine Kinase (SYK) ELISA Kit
Sign In for Pricing
View Details